OmniAb (OABI) Cash & Equivalents (2021 - 2026)
OmniAb (OABI) posted Cash & Equivalents of $24.34 million for Q2 2026, up 33.1% from $18.28 million a year earlier but down 16.2% from the prior quarter.
Powered by 
Analysis
OmniAb (OABI) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, OmniAb's Cash & Equivalents came in at $25.52 million, down 7.5% from FY2024.
- Annual Cash & Equivalents shows a three-year compound annual growth rate of -8.6% (FY2022 to FY2025).
- In prior years, OmniAb's Cash & Equivalents was $27.6 million in FY2024 (+68.7%), $16.36 million in FY2023 (-51.0%) and $33.39 million in FY2022.
- Quarterly Cash & Equivalents has run from a low of $19,847 in Q3 2022 to a high of $33.39 million in Q4 2022 over five years.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 29.9%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2022, with growth of 340.4%; the weakest was Q3 2022, with a decline of 94.5%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $29.05 million (Q1 2026), $25.52 million (Q4 2025) and $28.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | OmniAb | 708.05 Mn | 493.46 Mn | 12.81 Mn | 24.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.34 Mn |
| Mar 31, 2026 | 29.05 Mn |
| Dec 31, 2025 | 25.52 Mn |
| Sep 30, 2025 | 28.54 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 10.89 Mn |
| Dec 31, 2024 | 27.60 Mn |
| Sep 30, 2024 | 27.24 Mn |
| Jun 30, 2024 | 20.79 Mn |
| Mar 31, 2024 | 19.06 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | 21.25 Mn |
| Jun 30, 2023 | 20.99 Mn |
| Mar 31, 2023 | 22.91 Mn |
| Dec 31, 2022 | 33.39 Mn |
| Sep 30, 2022 | 19,847.00 |
| Jun 30, 2022 | 159,194.00 |
| Mar 31, 2022 | 434,629.00 |
| Sep 30, 2021 | 362,203.00 |
| Jun 30, 2021 | 36,145.00 |
API Access
OmniAb Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OABI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OABI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OABI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();